Vitalipid N

Medicinal product

(Invented) name

Vitalipid N

Active substance (s)

Retinolis/Fitomenadionas/Ergokalciferolis/Visų racematų alfa tokoferolis

Strength

69 µg/20 µg/1 µg/0,64 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Purpose for use

kūdikiams

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

B05XC, Vitamins

Marketing authorisation holder

Fresenius Kabi AB, Švedija

Date of authorisation

1995-10-04

Date of renewal

2008-11-24

Documents

Stage

Perregistruotas

Controlled?

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

1 ml koncentrato yra	1 ml
Retinolis	69 µg
Fitomenadionas	20 µg
Ergokalciferolis	1 µg
Visų racematų alfa tokoferolis	0,64 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
2671	8244	1008244	ampulė	10 ml N10		Receptinis	LT/1/95/1343/002	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2008-11-24	Perregistruotas
1995-10-04	Registruotas